Finance

Fearless Fund’s program for Black women entrepreneurs violates Civil Rights Act, appeals court rules

A U.S. federal court of appeals panel suspended a venture capital firm’s grant program for Black women business owners, ruling that a conservative...

‘Roaring Kitty’ post seems to show trader held onto giant GameStop stake after Monday’s rally

Keith Gill, known on Reddit under the pseudonym DeepFuckingValue and as Roaring Kitty, is seen on a fragment of a youtube video displayed...

Centerspace sets quarterly dividend at $0.75 per share By Investing.com

MINNEAPOLIS - Centerspace (NYSE: CSR), a real estate investment trust specializing in apartment communities, has declared a quarterly distribution of $0.75 per common...

EV’s will be profitable in a ‘couple years,’ Ford CEO Jim Farley

Electric vehicles can’t keep being money losers in perpetuity but for the time being, that’s exactly what they are.  In a wide-ranging interview, Ford...

Waste Management to acquire Stericycle in $7.2 billion deal

An employee cleans his company vehicle at the Waste Management facility in Austin, Texas, on Feb. 12, 2024.Brandon Bell | Getty ImagesWaste Management...

QuickLogic director Gary Tauss sells shares worth over $12k By Investing.com

Gary Tauss, a director at QuickLogic Corp (NASDAQ:), a semiconductor and related devices manufacturing company, recently sold shares in the company. The transactions,...

Outer Banks homes are collapsing due to climate change, but U.S. coastal property values are booming anyway

Suffering from rising sea levels, some North Carolina homes are literally underwater. Still, the overall waterfront property market is anything but, with price...

Spotify price increased again

Daniel Ek, founder and chief executive officer of Spotify, attends the Cannes Lions 2016 on June 22, 2016 in Cannes, France. Antoine Antoniol |...

Ascendis reports promising melanoma treatment results By Investing.com

COPENHAGEN - Ascendis Pharma A/S (NASDAQ:) has reported encouraging outcomes from its ongoing Phase 1/2 IL-Believe Trial, evaluating TransCon IL-2 β/γ therapy for...

Latest articles

spot_imgspot_img